| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0014-2999(92)90821-K |
| P698 | PubMed publication ID | 1478260 |
| P50 | author | Florence Noble | Q57267279 |
| P2093 | author name string | B. P. Roques | |
| S. Turcaud | |||
| M. C. Fournié-Zaluski | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | enkephalin | Q325101 |
| P304 | page(s) | 83-89 | |
| P577 | publication date | 1992-11-01 | |
| 1992-11-13 | |||
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Repeated systemic administration of the mixed inhibitor of enkephalin-degrading enzymes, RB101, does not induce either antinociceptive tolerance or cross-tolerance with morphine | |
| P478 | volume | 223 |
| Q39248479 | Allostery at opioid receptors: modulation with small molecule ligands. |
| Q33990607 | Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects. |
| Q52166326 | Analgesic doses of the enkephalin degrading enzyme inhibitor RB 120 do not have discriminative stimulus properties. |
| Q48375805 | Antinociception produced by the peptidase inhibitor, RB 101, in rats with adrenal medullary transplant into the spinal cord. |
| Q44346465 | CI 988, an antagonist of the cholecystokinin-B receptor, potentiates endogenous opioid-mediated antinociception at spinal level |
| Q39472701 | Characterization of the effects of opiorphin and sialorphin and their analogs substituted in position 1 with pyroglutamic acid on motility in the mouse ileum |
| Q36155156 | Comparing analgesia and mu-opioid receptor internalization produced by intrathecal enkephalin: requirement for peptidase inhibition |
| Q39220347 | Constitutive μ-opioid receptor activity leads to long-term endogenous analgesia and dependence |
| Q44038445 | Depressant effect on a C-fibre reflex in the rat, of RB101, a dual inhibitor of enkephalin-degrading enzymes. |
| Q43263146 | Effect of peptidases on the ability of exogenous and endogenous neurokinins to produce neurokinin 1 receptor internalization in the rat spinal cord |
| Q37998313 | Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain |
| Q36628062 | Inhibition of opioid release in the rat spinal cord by alpha2C adrenergic receptors |
| Q36649526 | Inhibition of opioid release in the rat spinal cord by serotonin 5-HT(1A) receptors |
| Q34536694 | N-methyl-D-aspartate receptors and large conductance calcium-sensitive potassium channels inhibit the release of opioid peptides that induce mu-opioid receptor internalization in the rat spinal cord |
| Q44347105 | Opioid-related changes in nociceptive threshold and in tissue levels of enkephalins after target disruption of the gene for neutral endopeptidase (EC 3.4.24.11) in mice |
| Q40263009 | Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids. |
| Q34602588 | Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drugs. |
| Q44026805 | RB101(S), a dual inhibitor of enkephalinases does not induce antinociceptive tolerance, or cross-tolerance with morphine: a c-Fos study at the spinal level. |
| Q34649847 | RB101-mediated protection of endogenous opioids: potential therapeutic utility? |
| Q52203788 | The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats. |
| Q89121908 | The Chemokine CCL4 (MIP-1β) Evokes Antinociceptive Effects in Mice: a Role for CD4+ Lymphocytes and Met-Enkephalin |
Search more.